Isosorbide dinitrate and Ultracet drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Isosorbide dinitrate (isosorbide dinitrate) and Ultracet (acetaminophen; tramadol hydrochloride). Common drug interactions include myocardial infarction among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Isosorbide dinitrate and Ultracet. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Isosorbide dinitrate?

Isosorbide dinitrate has active ingredients of isosorbide dinitrate. It is often used in angina. eHealthMe is studying from 13,180 Isosorbide dinitrate users. Check the latest studies of Isosorbide dinitrate.

What is Ultracet?

Ultracet has active ingredients of acetaminophen; tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 6,351 Ultracet users. Check the latest studies of Ultracet.



On Jul, 21, 2026

30 people who take Isosorbide dinitrate and Ultracet together, and have interactions are studied.

Isosorbide dinitrate and Ultracet drug interactions.

What are the common drug interactions of Isosorbide Dinitrate and Ultracet, by gender? *:

female:

  1. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  2. Rash pruritic (redness with itching)
  3. Pneumonia
  4. Abnormal faeces (abnormal stool)
  5. Acute respiratory failure
  6. Aortic arteriosclerosis (hardening of the aortic arteries)
  7. Aortic disorder
  8. Arthralgia (joint pain)
  9. Basophil count increased
  10. Blood glucose increased

male:

  1. Pneumonia
  2. Cachexia (loss of weight)
  3. Haemoglobin decreased
  4. Hip fracture
  5. Nausea (feeling of having an urge to vomit)
  6. Occult blood (blood in the faeces that is not visibly apparent)
  7. Productive cough
  8. Pyrexia (fever)
  9. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  10. Cough

What are the common drug interactions of Isosorbide Dinitrate and Ultracet, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Cardiac failure congestive
  2. Chronic kidney disease
  3. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Renal failure (kidney dysfunction)
  6. Renal injury (kidney injury)

50-59:

n/a

60+:

  1. Pneumonia
  2. Cachexia (loss of weight)
  3. Arthralgia (joint pain)
  4. Basophil count increased
  5. Blood glucose increased
  6. Blood magnesium increased
  7. Blood potassium increased
  8. Blood urea increased
  9. Bone callus excessive (excessive bony deposit formed between and around the broken ends of bone fractures)
  10. Contusion (a type of hematoma of tissue in which capillaries)

What are the existing conditions these people have? *

  1. High Blood Pressure: 15 people, 50.00%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 36.67%
  3. Constipation: 11 people, 36.67%
  4. Cough: 10 people, 33.33%
  5. High Blood Cholesterol: 9 people, 30.00%
  6. Diabetes: 9 people, 30.00%
  7. Type 2 Diabetes: 8 people, 26.67%
  8. Stable Angina (a constant chest pain): 7 people, 23.33%
  9. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 7 people, 23.33%
  10. Multiple Myeloma (cancer of the plasma cells): 7 people, 23.33%

* Approximation only. Some reports may have incomplete information.

Do you take Isosorbide dinitrate and Ultracet?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Isosorbide dinitrate and Ultracet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Isosorbide dinitrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ultracet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Isosorbide dinitrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ultracet and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on isosorbide dinitrate and acetaminophen; tramadol hydrochloride (the active ingredients of Isosorbide dinitrate and Ultracet, respectively), and Isosorbide dinitrate and Ultracet (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: